Dachaigh › Amyloidosis oighreachail co-cheangailte ri transthyretin › Oregon
Sgrùdaidhean clionaigeach Amyloidosis oighreachail co-cheangailte ri transthyretin ann an Oregon
Tha 4 sgrùdaidhean airson Amyloidosis oighreachail co-cheangailte ri transthyretin a’ lorg phàirtichean aig làraichean ann an Oregon.
Bailtean ann an Oregon
Teacsa sgrùdaidh oifigeil (Beurla)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Portland
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06465810Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06563895Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- Oregon Health & Science University, Portland
A’ fastadhÌre 2
Aoisean 40 gu 90 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
A’ fastadhÌre 3
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06128629Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.